Paper8543793
The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders.
Carrasco-Marin E and 3 others. J Immunol, 1996. Cited by 166 papers, by iCite.
Cite this record
ConductScience Library. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. Papers, record 8543793. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8543793
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigen Presentation | Major topic |
| Autoantigens | Major topic |
| Autoimmune Diseases | Major topic |
| Diabetes Mellitus, Type 1 | Major topic |
| Histocompatibility Antigens Class II | Major topic |
| Islets of Langerhans | Major topic |
| Mice, Inbred NOD | Major topic |
| Peptide Fragments | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Base Sequence | |
| Crosses, Genetic | |
| Disease Models, Animal | |
| Female | |
| Genes, MHC Class II | |
| Haplotypes | |
| Hybridomas | |
| Isoantigens | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C57BL | |
| Mice, Inbred CBA | |
| Mice, SCID | |
| Molecular Sequence Data | |
| Mutagenesis, Site-Directed | |
| Sodium Dodecyl Sulfate |
Source PubMed
Cited by68
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 166 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38709934 | Aire mediates tolerance to insulin through thymic trimming of high-affinity T cell clones. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38709934 | PubMed |
| 34204485 | Strength and Numbers: The Role of Affinity and Avidity in the 'Quality' of T Cell Tolerance. | Cells | 2021 | https://conductscience.org/library/papers/34204485 | PubMed |
| 33603744 | The Role of T Cell Receptor Signaling in the Development of Type 1 Diabetes. | Front Immunol | 2020 | https://conductscience.org/library/papers/33603744 | PubMed |
| 33451011 | Complement as a Therapeutic Target in Systemic Autoimmune Diseases. | Cells | 2021 | https://conductscience.org/library/papers/33451011 | PubMed |
| 33095259 | Lysosomal cathepsin creates chimeric epitopes for diabetogenic CD4 T cells via transpeptidation. | J Exp Med | 2021 | https://conductscience.org/library/papers/33095259 | PubMed |
| 32507505 | Tolerization of recent thymic emigrants is required to prevent RBC-specific autoimmunity. | J Autoimmun | 2020 | https://conductscience.org/library/papers/32507505 | PubMed |
| 31540941 | Single-Cell Analysis of CD4 T Cells in Type 1 Diabetes: From Mouse to Man, How to Perform Mechanistic Studies. | Diabetes | 2019 | https://conductscience.org/library/papers/31540941 | PubMed |
| 31387620 | Transplantation of MHC-mismatched mouse embryonic stem cell-derived thymic epithelial progenitors and MHC-matched bone marrow prevents autoimmune diabetes. | Stem Cell Res Ther | 2019 | https://conductscience.org/library/papers/31387620 | PubMed |
| 30349037 | LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII. | Nat Immunol | 2018 | https://conductscience.org/library/papers/30349037 | PubMed |
| 30185635 | Rapid CLIP dissociation from MHC II promotes an unusual antigen presentation pathway in autoimmunity. | J Exp Med | 2018 | https://conductscience.org/library/papers/30185635 | PubMed |
| 30122420 | Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes. | J Autoimmun | 2019 | https://conductscience.org/library/papers/30122420 | PubMed |
| 29463744 | MHC-mismatched mixed chimerism restores peripheral tolerance of noncross-reactive autoreactive T cells in NOD mice. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/29463744 | PubMed |
| 26453556 | N-terminal additions to the WE14 peptide of chromogranin A create strong autoantigen agonists in type 1 diabetes. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26453556 | PubMed |
| 25485681 | Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA. | J Clin Invest | 2015 | https://conductscience.org/library/papers/25485681 | PubMed |
| 25379761 | Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome. | PLoS One | 2014 | https://conductscience.org/library/papers/25379761 | PubMed |
| 24324466 | MHC Class II Protein Turnover In vivo and Its Relevance for Autoimmunity in Non-Obese Diabetic Mice. | Front Immunol | 2013 | https://conductscience.org/library/papers/24324466 | PubMed |
| 24150607 | Autoantigen-induced focusing of Vβ13+ T cells precedes onset of autoimmune diabetes in the LEW.1WR1 rat. | Diabetes | 2014 | https://conductscience.org/library/papers/24150607 | PubMed |
| 24133494 | MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity. | Front Immunol | 2013 | https://conductscience.org/library/papers/24133494 | PubMed |
| 23895744 | Destabilization of peptide:MHC interaction induces IL-2 resistant anergy in diabetogenic T cells. | J Autoimmun | 2013 | https://conductscience.org/library/papers/23895744 | PubMed |
| 23677470 | Accelerated turnover of MHC class II molecules in nonobese diabetic mice is developmentally and environmentally regulated in vivo and dispensable for autoimmunity. | J Immunol | 2013 | https://conductscience.org/library/papers/23677470 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8543793
GET https://conductscience.org/api/papers/v1/8543793/cited_by?page=2